MENU
+Compare
IQSI
ETF ticker: NYSE ARCA
AS OF
Sep 5, 04:15 PM (EDT)
Price
$33.86
Change
+$0.20 (+0.59%)
Net Assets
213.68M

IQSI stock forecast, quote, news & analysis

The investment seeks investment results that track (before fees and expenses) the price and yield performance of its underlying index, the NYLI Candriam International Equity Index... Show more

IQSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for IQSI with price predictions
Sep 04, 2025

IQSI in upward trend: 10-day moving average broke above 50-day moving average on August 12, 2025

The 10-day moving average for IQSI crossed bullishly above the 50-day moving average on August 12, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

IQSI moved above its 50-day moving average on August 06, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IQSI advanced for three days, in of 333 cases, the price rose further within the following month. The odds of a continued upward trend are .

IQSI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 308 cases where IQSI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for IQSI moved out of overbought territory on August 21, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on August 29, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on IQSI as a result. In of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for IQSI turned negative on August 29, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IQSI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are AstraZeneca PLC (NASDAQ:AZN), Merck & Co (NYSE:MRK), NXP Semiconductors NV (NASDAQ:NXPI), Suncor Energy (NYSE:SU), JD.com (NASDAQ:JD), Prudential Financial (NYSE:PRU), EQT Corp (NYSE:EQT), Archer Daniels Midland Company (NYSE:ADM), CyberArk Software Ltd (NASDAQ:CYBR), Marathon Oil Corp (null:MRO).

Industry description

The investment seeks investment results that track (before fees and expenses) the price and yield performance of its underlying index, the NYLI Candriam International Equity Index. The Advisor employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. The underlying index is designed to deliver exposure to equity securities of companies meeting environmental, social and corporate governance (ESG) criteria developed by Candriam and weighted using a market-capitalization weighting methodology.

Market Cap

The average market capitalization across the NYLI Candriam International Equity ETF ETF is 37.3B. The market cap for tickers in the group ranges from 348.67K to 313.43B. SAP holds the highest valuation in this group at 313.43B. The lowest valued company is NEXI at 348.67K.

High and low price notable news

The average weekly price growth across all stocks in the NYLI Candriam International Equity ETF ETF was 15%. For the same ETF, the average monthly price growth was 158%, and the average quarterly price growth was 119%. GMAB experienced the highest price growth at 9%, while MB experienced the biggest fall at -14%.

Volume

The average weekly volume growth across all stocks in the NYLI Candriam International Equity ETF ETF was 7%. For the same stocks of the ETF, the average monthly volume growth was 10% and the average quarterly volume growth was -14%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 53
Price Growth Rating: 52
SMR Rating: 63
Profit Risk Rating: 55
Seasonality Score: -17 (-100 ... +100)
View a ticker or compare two or three
IQSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category ForeignLargeBlend

Profile
Fundamentals
Details
Category
Foreign Large Blend
Address
800 Westchester Avenue,Suite N611Rye Brook
Phone
1-888-934-0777
Web
www.indexiq.com